Description
Gaudium IVF and Women Health Limited (ticker: 544709) will be added to the BSE IPO Index effective March 4, 2026, following its listing on BSE on February 27, 2026.
Summary
BSE has announced the addition of Gaudium IVF and Women Health Limited (Exchange ticker: 544709) to the BSE IPO Index. The company was listed on BSE on February 27, 2026, and will be included in the index effective at the open of Wednesday, March 4, 2026.
Key Points
- Gaudium IVF and Women Health Limited (ticker: 544709) listed on BSE on February 27, 2026.
- The stock will be added to the BSE IPO Index effective March 4, 2026 (market open).
- The corporate action has been included in the end-of-day corporate action file (*.SDE) dated February 27, 2026.
- Reference circular: Notice No. 20260226-41.
Regulatory Changes
No regulatory changes. This is a routine index rebalancing action following a new listing on BSE.
Compliance Requirements
Index-linked fund managers, ETF providers, and other entities tracking the BSE IPO Index should update their portfolios to include Gaudium IVF and Women Health Limited (544709) effective at the open of March 4, 2026. Queries may be directed to bseindex@bseindia.com.
Important Dates
- February 27, 2026: Gaudium IVF and Women Health Limited listed on BSE; end-of-day corporate action file (*.SDE) updated.
- March 4, 2026 (market open): Effective date for addition of 544709 to the BSE IPO Index.
Impact Assessment
The impact is limited to index-tracking products benchmarked against the BSE IPO Index. Fund managers and ETF operators tracking this index will need to incorporate the new constituent. No broader market or regulatory impact is anticipated.
Impact Justification
Routine index constituent addition following a new IPO listing; affects only index-tracking funds and products benchmarked against the BSE IPO Index.